Axon Targeting’s Switch Lives in the Cell Body: Observed Here, Not Operated
A research article in PNAS from Alexander Jaworski’s laboratory at Brown University’s Carney Institute for Brain Science. The team used a custom genetic tool to isolate commissural neurons, which connect the left and right sides of the central nervous system, from rodent cells at four stages of development. They then profiled gene expression by single-cell RNA sequencing. Commissural neurons were chosen because their axons make a sharp, unmistakable change of direction as they cross the spinal cord midline.
- The control point is the nucleus, not the growth cone. Conventional understanding held that guidance decisions are made at the axon tip, on the reasoning that axons are long and respond rapidly to local cues. The team reports a genetic switch operating in the cell body instead.
- Gene expression shifts as the axon passes the waystation. Crossing the midline coincided with the neuron turning entire groups of genes on and off, which changed which guidance molecules appeared at the axon tip and directed it toward the next checkpoint.
- The switch is sequential rather than continuous. The accompanying image shows the guidance molecule L1 expressed only after axons have crossed the midline, which is the visual form of the same claim.
- A resource came out alongside the finding. The work generated expression data for more than 12,000 neurons across developmental stages, well beyond those involved in pathfinding, which the authors describe as a genetic atlas of the spinal cord.
This reframes why a therapeutic field has repeatedly failed. Neural regeneration programmes have been able to make axons grow for years, through several mechanistic routes, and the researchers state the persistent problem plainly: axons can be made to grow but not to travel to the right place. If targeting is set by a transcriptional programme in the cell body rather than by the growth cone reading its surroundings, then every intervention optimised for growth has been addressing the achievable half of a two-part problem. An axon that regenerates without its guidance programme is an axon going somewhere unhelpful. That is a specific and checkable reason to ask any neuroregeneration asset what it does about targeting, separately from what it does about growth.